| IHC marker | Positivity | Percentage | Notes | References |
| PAN-keratin | 10/10 | 100% | Including AE1/AE3 keratin | [4–11] | Alfa-lactalbumin | 1/1 | 100% | | [9] | Amylase | 1/1 | 100% | | [9] | Ber-ep4 | 1/2 | 50% | | [12] | Blood group isoantigens | 0/1 | 0% | | [9] | B2-microglobulin | 0/1 | 0% | | [9] | Calponin | 2/2 | 100% | | [11] | CAM5.2 | 0/1 | 0% | | [5] | CD10 | 1/2 | 50% | | [5, 12] | CD43 | 2/3 | 66,6% | | [13] | CD56 | 1/1 | 100% | | [5] | CD57 (Leu7) | 0/1 | 0% | | [8] | CD117 | 37/37 | 100% | | [1, 5, 6, 12–16] | CEA | 24/33 | 72,7% | Focal, luminal positivity | [1, 5–8, 11, 12, 17–22] | CK5/6 | 17/17 | 100% | | [5, 14] | CK7 | 20/20 | 100% | | [5, 10, 12, 14] | CK10 | 0/1 | 0% | | [10] | CK15 | 13/14 | 92,8% | | [14] | CK18 | 1/1 | 100% | | [10] | CK19 | 1/2 | 50% | | [5, 12] | CK20 | 0/1 | 0% | | [5] | D2-40 | 13/15 | 86,6% | | [14] | EMA | 27/30 | 90% | Focal, luminal positivity | [1, 4–6, 8, 9, 11, 12, 17–19, 22, 23] | GCDFP-15 | 0/1 | 50% | | [12] | HMWCK | 6/6 | 100% | Including 34Be12 clone | [5, 11, 17, 18, 21] | Laminin | 3/3 | 100% | | [17, 24] | LMWK | 4/4 | 100% | | [8, 17, 18, 21] | MNF-116 | 14/14 | 100% | | [1, 22] | P16 | 1/1 | 100% | | [16] | P63 | 17/19 | 89,4% | | [5, 12, 14] | Peanut agglutinin (PNA) | 1/1 | 100% | | [9] | S-100 | 28/30 | 93,3% | Generally focal positivity | [1, 5–9, 11, 12, 17–23] | SMA | 33/36 | 91,6% | Including one immunoflourescent study | [1, 5, 10, 11, 14, 18, 20] | SOX-10 | 19/19 | 100% | | [14] | Type IV collagen | 12/13 | 92,3% | | [1, 17, 24] | Vimentin | 13/16 | 81,2% | | [8, 10, 14] |
|
|